| Similar Articles |
|---|
 |
Chemistry World
November 28, 2012
Andrew Turley |
GSK expands in India and Nigeria GlaxoSmithKline is to spend 650 million pounds dramatically increasing its ownership of Indian and Nigerian subsidiaries.   |
The Motley Fool
April 15, 2011
Frank Vinluan |
GSK to Shed Weight Loss Drug alli and 18 Others GSK wants to focus on fast-growing "priority brands." |
Chemistry World
April 25, 2014
Andy Extance |
$25bn-plus trade sharpens pharma giants' focus Three leading pharmaceutical firms are set to exchange business segments valued at over $25 billion, in deals affecting at least 14,000 employees. |
Chemistry World
April 19, 2013
Phillip Broadwith |
Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws. |
The Motley Fool
October 17, 2011
Navneet Bajaj |
Juicy Returns at National Beverage National Beverage reports a first quarter sales increase. |
Chemistry World
October 2011
Bibiana Campos Seijo |
Editorial: Odd Couple McLaren's expertise in building Formula One cars is to be put to use in the manufacture of antibiotics, vaccines and Lucozade in an unlikely alliance between the motor racing team and GlaxoSmithKline. |
The Motley Fool
April 5, 2011
Frank Vinluan |
GSK in Emerging Markets: Why Sales Staff There Are Key to Global Strategy GlaxoSmithKline's rivalry with top drug companies such as Pfizer goes beyond the products they sell. In some emerging markets, it now also extends to the staff they're fighting to keep. |
Chemistry World
March 8, 2011
Andy Extance |
GSK will pay off UK graduate tuition fees Potential undergraduate chemistry students concerned about their prospects in the face of plant closures and increased tuition fees have been given some cheer by pharmaceutical giant GlaxoSmithKline. |
Chemistry World
December 5, 2014
Andy Extance |
GSK cuts US jobs in push for savings 350 of the chemists, engineers and other roles will be lost by April 2015, another 450 by July, and the remainder eliminated by the end of the year. |
The Motley Fool
January 12, 2012
Isaac Pino |
How American Brands Rule the World The best global brands can provide a boost to your portfolio. |
The Motley Fool
January 19, 2011
Cliff D'Arcy |
Glaxo Stung by Legal Bill GSK shareholders are hit by costly legal settlements. |
The Motley Fool
October 26, 2006
Brian Lawler |
Glaxo's Prescription for Sagging Sales Trading at roughly 32 times its trailing-12-month earnings, and with a solid 2.9% dividend yield, GSK is a fine investment for shareholders patient enough to wait until 2008 for a return to solid revenue growth. |
The Motley Fool
July 26, 2011
Cliff D'Arcy |
GSK Showers Shareholders With Cash GlaxoSmithKline, the U.K.'s largest pharmaceutical company, has released its second-quarter results. Thanks to rising earnings and dividends, its shares remain attractively priced, particularly to income-seeking investors. |
Chemistry World
July 2, 2012
Andrew Turley |
$3bn GSK fine sets new industry record The GlaxoSmithKline fine, which relates to antidepressant brands Paxil (paroxetine) and Wellbutrin (bupropion) and diabetes brand Avandia (rosiglitazone), is the largest payment ever made by a drug company. |
BusinessWeek
August 6, 2007
Kenji Hall |
Fad Marketing's Balancing Act In Japan, Pepsi's limited edition flavors can be huge hits - and then it kills them. |
Food Processing
August 2011 |
New Food Rollout: August 2011 New food and beverage products now available on store shelves. |
Food Processing
June 2010 |
New Food Rollout: June 2010 New food and beverage products hitting the shelves just in time for summer. |
Food Processing
July 2011
Diane Toops |
Food Processors Find Public Growth for Private Label The price differential between branded food and store brands is still there, augmented by higher quality and healthier formulations. |
The Motley Fool
June 14, 2007
Brian Lawler |
Dueling Fools: GlaxoSmithKline Bull Shares of the pharmaceutical may be temporarily down, but it's not out. |
HBS Working Knowledge
September 20, 2004
Holt, Quelch, & Taylor |
How Consumers Value Global Brands What do consumers expect of global brands? Does it hurt to be an American brand? This Harvard Business Review excerpt identifies the three characteristics consumers look for to make purchase decisions. |
The Motley Fool
November 3, 2011
Frank Vinluan |
GSK Settles With Uncle Sam for $3B GSK said the settlement will reduce financial uncertainty for the company and is in the best interest of shareholders. |
Chemistry World
August 6, 2014
Hepeng Jia |
GSK's China troubles continue The company faces official prosecution over accusations of bribery and corruption, litigation from fired employees and an upcoming trial of private investigators employed to look into a blackmail attempt. |
Chemistry World
May 16, 2013
Anthony King |
GSK partners Save the Children for Africa project Pharma giant GSK is to partner the international charity Save the Children in a five year deal, which it says aims to help save the lives of one million children. The controversial compact offers a blueprint for how businesses and non-government organizations can work together, says GSK. |
BusinessWeek
January 29, 2007
Kerry Capell |
GlaxoSmithKline: Getting AIDS Drugs To More Sick People GlaxoSmithKline sells 90% of its vaccines, in volume terms, at not-for-profit prices to customers in the developing world. |
